Skip to main content
. 2020 Mar 24;64(4):e00099-20. doi: 10.1128/AAC.00099-20

TABLE 2.

Antimicrobial activity of rezafungin tested against the main organisms and organism groups from all years using the CLSI method

Organism/organism group (no. of isolates) No. (cumulative %) of isolates inhibited at MIC (μg/ml) ofa:
MIC (μg/ml)
≤0.002 0.004 0.008 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 >b 50% 90%
Candida albicans (835) 11 (3.8) 6 (5.8) 87 (10.4) 270 (42.8) 309 (79.8) 139 (96.4) 28 (99.8) 2 (100.0) 0.03 0.06
    2016 (276) 13 (4.7) 100 (40.9) 113 (81.9) 38 (95.7) 11 (99.6) 1 (100.0) 0.03 0.06
    2017 (267) 12 (4.5) 83 (35.6) 96 (71.5) 66 (96.3) 10 (100.0) 0.03 0.06
    2018 (292) 11 (3.8) 6 (5.8) 45 (21.2) 87 (51.0) 100 (85.3) 35 (97.3) 7 (99.7) 1 (100.0) 0.015 0.06
Candida glabrata (374) 1 (0.3) 0 (0.3) 0 (0.3) 5 (1.6) 136 (38.0) 162 (81.3) 54 (95.7) 6 (97.3) 3 (98.1) 3 (98.9) 4 (100.0) 0.06 0.12
    2016 (135) 0 (0.0) 1 (0.7) 38 (28.9) 65 (77.0) 27 (97.0) 3 (99.3) 0 (99.3) 0 (99.3) 1 (100.0) 0.06 0.12
    2017 (121) 0 (0.0) 33 (27.3) 60 (76.9) 20 (93.4) 2 (95.0) 3 (97.5) 2 (99.2) 1 (100.0) 0.06 0.12
    2018 (118) 1 (0.8) 0 (0.8) 0 (0.8) 4 (4.2) 65 (59.3) 37 (90.7) 7 (96.6) 1 (97.5) 0 (97.5) 1 (98.3) 2 (100.0) 0.03 0.06
Candida parapsilosis (329) 0 (0.0) 1 (0.3) 0 (0.3) 0 (0.3) 1 (0.6) 5 (2.1) 62 (21.0) 134 (61.7 124 (99.4) 2 (100.0) 1 2
    2016 (94) 0 (0.0) 2 (2.1) 13 (16.0) 37 (55.3) 42 (100.0) 1 2
    2017 (118) 0 (0.0) 1 (0.8) 0 (0.8) 0 (0.8) 0 (0.8) 2 (2.5) 14 (14.4) 48 (55.1) 51 (98.3) 2 (100.0) 1 2
    2018 (117) 0 (0.0) 1 (0.9) 1 (1.7) 35 (31.6) 49 (73.5) 31 (100.0) 1 2
Candida tropicalis (196) 12 (6.1) 52 (32.7) 75 (70.9) 41 (91.8) 11 (97.4) 3 (99.0) 0 (99.0) 1 (99.5) 1 (100.0) 0.03 0.06
    2016 (64) 3 (4.7) 20 (35.9) 24 (73.4) 12 (92.2) 3 (96.9) 0 (96.9) 0 (96.9) 1 (98.4) 1 (100.0) 0.03 0.06
    2017 (54) 0 (0.0) 11 (20.4) 19 (55.6) 17 (87.0) 5 (96.3) 2 (100.00) 0.03 0.12
    2018 (78) 0 (0.0) 9 (11.5) 21 (38.5) 32 (79.5) 12 (94.9) 3 (98.7) 1 (100.0) 0.03 0.06
Candida krusei (77) 0 (0.0) 22 (28.6) 31 (68.8) 17 (90.9) 7 (100.0) 0.03 0.06
    2016 (33) 0 (0.0) 8 (24.2) 17 (75.8) 7 (97.0) 1 (100.0) 0.03 0.06
    2017 (28) 0 (0.0) 3 (10.7) 12 (53.6) 10 (89.3) 3 (100.0) 0.03 0.12
    2018 (16) 0 (0.0) 11 (68.8) 2 (81.2) 0 (81.2) 3 (100.0) 0.015 0.12
Candida dubliniensis (93) 1 (1.1) 0 (1.1) 1 (2.2) 4 (6.5) 30 (38.7) 39 (80.6) 18 (100.0) 0.06 0.12
    2016 (30) 0 (0.0) 8 (26.7) 15 (76.7) 7 (100.0) 0.06 0.12
    2017 (28) 0 (0.0) 1 (3.6) 9 (35.7) 11 (75.0) 7 (100.0) 0.06 0.12
    2018 (35) 1 (2.9) 0 (2.9) 1 (5.7) 3 (14.3) 13 (51.4) 13 (88.6) 4 (100.0) 0.03 0.12
Cryptococcus neoformans var. grubii (73) 0 (0.0) 9 (12.3) 64 (100.0) >4 >4
    2016 (27) 0 (0.0) 27 (100.0) >4 >4
    2017 (25) 0 (0.0) 7 (28.0) 18 (100.0) >4 >4
    2018 (21) 0 (0.0) 2 (9.5) 19 (100.0) >4 >4
Aspergillus fumigatus (183) 3 (4.0) 64 (36.6) 88 (84.7) 28 (100.0) 0.015 0.03
    2016 (48) 26 (54.2) 20 (95.8) 2 (100.0) ≤0.008 0.015
    2017 (60) 25 (41.7) 29 (90.0) 6 (100.0) 0.015 0.015
    2018 (75) 0 (0.0) 3 (4.0) 13 (21.3) 39 (73.3) 20 (100.0) 0.015 0.03
Aspergillus section Flavi (45) 5 (33.3) 20 (55.6) 18 (95.6) 2 (100.0) ≤0.008 0.015
    2016 (12) 3 (25.0) 7 (83.3) 2 (100.0) 0.015 0.03
    2017 (18) 8 (44.4) 10 (100.0) 0.015 0.015
    2018 (15) 0 (0.0) 5 (33.3) 9 (93.3) 1 (100.0) 0.008 0.008
a

During the 2016 and 2017 study years, the lowest echinocandins concentration tested was 0.008 μg/ml. The range was expanded to 0.002 μg/ml in 2018.

b

>, greater than the last concentration tested.